Why the study?
Does pulmonary valve replacement using a beating heart technique improve right ventricular dimensions and clinical status in patients with corrected tetralogy of Fallot?
Observational (n=99)
No
Does pulmonary valve replacement using a beating heart technique improve right ventricular dimensions and clinical status in patients with corrected tetralogy of Fallot?
Answers are grounded in this paper and cite their sources.
In patients with corrected tetralogy of Fallot, pulmonary valve replacement using a beating heart technique significantly reduces right ventricular dimensions and improves clinical functional class with low perioperative mortality.
Introduction: Development of pulmonary insufficiency in patients with surgically corrected tetralogy of Fallot (TOF) may lead to severe right heart failure with serious consequences. We herein present our experience with pulmonary valve replacement (PVR) in these patients. Methods: From 2005-2013, 99 consecutive patients (71 males/28 females, mean age 38±8 years), underwent PVR after 7 to 40 (mean 29 ± 8) years from the initial correction. Seventy nine of the symptomatic patients presented in NYHA II, 14 in III and 2 in IV. All underwent PVR with a stented bioprosthetic valve, employing a beating heart technique with normothermic extracorporeal circulation support. Concomitant procedures included resection of aneurysmal outflow tract patches (n = 37), tricuspid valve annuloplasty (n = 36), augmentation of stenotic pulmonary arteries (n = 9), maze procedure (n = 2) and pulmonary artery stenting (n = 4). Results: There were 2 perioperative deaths (2%). One patient developed sternal dehiscence requiring rewiring. Median ICU and hospital stay was 1 and 7 days respectively. Postoperative echocardiography at 6 and 12 months showed excellent bioprosthetic valve performance, significant decrease in size of the right cardiac chambers and reduction of tricuspid regurgitation (TR) in the majority of the patients. At mean follow-up of 3.6 ± 2 years, all surviving patients remain in excellent clinical condition. Conclusion: Probability of reoperation for pulmonary insufficiency in patients with surgically corrected TOF increases with time and timely PVR by preventing the development of right heart failure is crucial for long-term survival. Current bioprosthetic valve technology in combination with the beating heart technique provides excellent immediate and short-term results. Further follow-up is necessary to evaluate long-term outcome.
No takes yet. Share an insight, caveat, or question.
Mitropoulos et al. (2017) conducted an observational in Corrected tetralogy of Fallot with pulmonary regurgitation (n=99). Pulmonary valve replacement with stented bioprosthetic valve vs. Preoperative baseline was evaluated on Right ventricular end diastolic diameter (RVEDD) (p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: